1. Search Result

Search Result

Results for "189060-13-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-16274
    Lapaquistat acetate

    TAK-475

    Farnesyl Transferase Metabolic Disease
    Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor, blocking the conversion of farnesyl diphosphate (FPP) to squalene. Lapaquistat acetate (TAK-475) is originally intended use to Mevalonate Kinase Deficiency (MKD), it is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage.